Related Experiment Video

Updated: Jul 1, 2026

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

Catastrophic CD34+ autologous hematopoietic stem cell collection despite sustained mobilization and solutions to

Laurence Raoult-Valette1, Arnaud Campidelli2, Isabelle Boutin3

  • 1Centre de soins Service d'aphérèse, Etablissement Français du Sang (EFS), Versailles, France.

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|June 29, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
continuous collectioncytapheresishematopoietic stem cell collectionmobilization

More Related Videos

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells
22:06

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells

Published on: February 25, 2007

Related Experiment Videos

Last Updated: Jul 1, 2026

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells
22:06

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells

Published on: February 25, 2007

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Articles linked to this work by shared authors, journal, and citation graph.

Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.

European journal of cancer (Oxford, England : 1990)·2026

Hemophagocytic lymphohistiocytosis-like syndrome after CD19-directed CAR T-cells for B-cell lymphoma and B-cell acute lymphoblastic leukemia: A LYSA, SFCE, and GRAALL study from the DESCAR-T registry.

HemaSphere·2026

Intensified Rituximab, Methotrexate, Procarbazine, and Cytarabine (R-MPVA) Regimen With Sequential Addition of Etoposide to R-MPV and Ifosfamide to R-AraC for Newly Diagnosed Primary CNS Lymphoma Patients Aged Between 60 and 70 Years: An LOC Network Study.

Hematological oncology·2026

Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm.

Journal of hematology & oncology·2026

Prolonged survival with glofitamab in non-diffuse large B-cell lymphoma after CAR T-cell therapy relapse.

Haematologica·2026

[Storage and disposal of cryopreserved cellular products and associated samples (SFGM-TC)].

Bulletin du cancer·2026

National blood-service continuity during armed conflict: a 39-day operational analysis of collection, redistribution and red-cell inventory in Iran.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026

Structured Donor Re-engagement Following Temporary Deferral: A Prospective Implementation Study of Donor Re-entry.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026

Post-transfusion purpura: pathogenic mechanisms and relationship with immune thrombocytopenia: a critical analytical review.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026

Knowledge management in computerised systems validation at GMP facilities: A qualitative interview study with specialists in the Austrian public health sector.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026

Pattern of blood donor deferral and donor return following structured telephonic follow-up in a tertiary care blood centre in India.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026

Infectious risks of transfusion: A 10-year look back and perspectives.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026

Perioperative Hospital-at-Home Program: A Scoping Review.

World journal of surgery·2026

Implications of Glucagon-Like Peptide-1 Signaling for Hemophilic Arthropathy, Joint Inflammation, and Cartilage Degeneration: A Narrative Review.

Haemophilia : the official journal of the World Federation of Hemophilia·2026

Generational Differences in Illness-Related Uncertainty Among Haemophilia Carriers: A Qualitative Study Using Mishel's Uncertainty in Illness Theory.

Haemophilia : the official journal of the World Federation of Hemophilia·2026

High Prevalence and Clinical Burden of Bleeding Disorder of Unknown Cause in Adolescents With Heavy Menstrual Bleeding: Application of New Definition by the International Society on Thrombosis and Haemostasis.

Haemophilia : the official journal of the World Federation of Hemophilia·2026

Synovial Metal Binding Proteins in Haemophilic Arthropathy: Potential Biomarkers and Therapeutic Targets.

Haemophilia : the official journal of the World Federation of Hemophilia·2026

Perioperative Management in Persons With Haemophilia on Rebalancing Therapies: A Narrative Review.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us